New Drugs and Targets for Asthma & COPD
Imperial College / National Heart & Lung Institute
Archive
19.11.2008 - 21.11.2008 London
Course Content
This course is focussed on the identification of new targets and development of new approaches and therapies for asthma, allergy and COPD. These conditions cause a large and increasing global burden of disease. Presentations by clinical academics and senior members of the pharmaceutical industry cover the latest breakthroughs in research and clinical development of new drugs in this rapidly changing area. The course will be of particular relevance to those in the pharmaceutical industry, researchers in respiratory medicine, and specialised clinicians and health care professionals
This course is focussed on the identification of new targets and development of new approaches and therapies for asthma, allergy and COPD. These conditions cause a large and increasing global burden of disease. Presentations by clinical academics and senior members of the pharmaceutical industry cover the latest breakthroughs in research and clinical development of new drugs in this rapidly changing area. The course will be of particular relevance to those in the pharmaceutical industry, researchers in respiratory medicine, and specialised clinicians and health care professionals
Notes
(£250 daily rate) Special rate for SpRs: £300
(£250 daily rate) Special rate for SpRs: £300
Languages
English
English
Fees
GBP 650,00
GBP 650,00
Organizer contact info
Dovehouse Street
SW3 6LY
United Kingdom
Dovehouse Street
SW3 6LY
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
